In The News

January 25, 2023 | In The News
Endpoints News: A stem cell pioneer sent an experiment into space. Patients are the next frontier
January 05, 2023 | In The News
BioCentury: BioCentury’s 2022 class of emerging companies
December 06, 2022 | In The News
Endpoints News: Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform
August 23, 2022 | In The News
BioCentury: Medical Excellence to fund cell, gene therapy, AI and regenerative medicine with $145M debut fund
August 23, 2022 | In The News
Wall Street Journal: Life Sciences Venture Investor MEC Raises $145 Million Fund
March 01, 2022 | In The News
ALS News Today: ProJenX Launches, Will Develop ALS Therapy Prosetin
January 12, 2022 | In The News
MEC SAB in the News: Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours
November 16, 2021 | In The News
Endpoints News: Out to prove the next big I/O target, Immunitas’ chief dealmaker steps up to CEO role
August 19, 2021 | In The News
FinSMEs: Immunitas Therapeutics Closes $58M in Series B Financing
August 18, 2021 | In The News
Endpoints: Touting CD161 as a test case for single-cell tech, Longwood-backed Immunitas bags $58M for next-gen I/O work